Table 1.
The characteristics of COVID‐19 patients treated with TCZ
| Case No. | Age | Sex | Clinical classification | Co‐morbidity | Therapy | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 0 | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | |||||
| 1 | 73 | M | Critically ill | Hypertension | TCZ 480 mg MP 40 mg | MP 40 mg | MP 40 mg | MP 40 mg | … | … | … | … |
| 2 | 62 | M | Critically ill | None | TCZ 600 mg MP 40 mg | MP 40 mg bid | MP 40 mg bid | MP 40 mg bid | … | … | … | … |
| 3 | 62 | M | Critically ill | Hypertension | TCZ 320 mg MP 80 mg bid | MP 80 mg bid | MP 80 mg bid | MP 80 mg bid | MP 80 mg bid | MP 80 mg bid | … | … |
| 4 | 74 | M | Critically ill | Hypertension Stroke history | TCZ 480 mg | … | … | TCZ 480 mg | … | … | … | … |
| 5 | 72 | M | Critically ill | Hypertension | TCZ 100 mg | TCZ 240 mg | … | … | … | … | … | … |
| 6 | 73 | M | Critically ill | None | TCZ 80 mg | TCZ 160 mg | TCZ 80 mg | … | … | … | … | … |
| 7 | 65 | M | Critically ill | Hypertension Stroke history | TCZ 480 mgMP 40 mg | MP 40 mg bid | MP 80 mg bid | MP 80 mg bid | MP 80 mg bid | MP 80 mg bid | … | … |
| 8 | 66 | F | Seriously ill | Stroke history | TCZ 480 mg MP 80 mg | MP 80 mg | MP 80 mg | MP 80 mg | … | … | … | … |
| 9 | 73 | M | Seriously ill | Hypertension Diabetes | TCZ 480 mg | … | TCZ 480 mg | … | … | … | … | … |
| 10 | 77 | M | Seriously ill | Hypertension Diabetes | TCZ 400 mg | … | … | … | … | … | … | … |
| 11 | 65 | F | Seriously ill | Hypertension Diabetes | TCZ 400 mg MP 40 mg | MP 40 mg bid | MP 40 mg bid | MP 40 mg bid | MP 40 mg | MP 40 mg | MP 40 mg | … |
| 12 | 77 | M | Seriously ill | Hypertension Diabetes | TCZ 400 mg | … | … | … | … | … | … | … |
| 13 | 75 | M | Moderately ill | None | TCZ 480 mg MP 40 mg | MP 40 mg bid | MP 40 mg bid | MP 40 mg bid | MP 40 mg bid | … | … | … |
| 14 | 77 | M | Moderately ill | None | TCZ 80 mg | TCZ 160 mg | TCZ 80 mg | … | … | … | … | … |
| 15 | 80 | F | Seriously ill | None | TCZ 240 mg MP 40 mg | MP 40 mg bid | MP 40 mg bid | MP 40 mg bid | … | … | MP 20 mg | MP 20 mg |
Abbreviations: bid, twice a day; F, female; M, male; MP, methylprednisolone; TCZ, tocilizumab.